Pentetrazol (Balance Therapeutics)

N/A

Report date: 2025/12/02 15:15:59

Base Information

Drug NamePentetrazol (Balance Therapeutics)
Drug Alias NamePentylenetetrazoleBTD-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCentral nervous system stimulantsGABA-A receptor; benzodiazepine site antagonists
TargetsGABA-A receptor; benzodiazepine site
Therapy Area/IndicationsCataplexyIdiopathic Hypersomnia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBalance Therapeutics Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsCataplexyIdiopathic Hypersomnia

Other Information

ATC CodeN/A
Related LinksN/A